Laboratory Information System
XIFIN LIS 5 is the only SaaS-based LIS platform that offers multi-specialty workflows and collaboration tools necessary to support precision medicine programs.
INTRODUCING XIFIN LIS 5
Increases laboratory testing capacity, shortens turnaround time, creates new revenue stream opportunities and makes it easier to connect to other healthcare partners. XIFIN LIS improves operational efficiencies and delivers flexibility necessary for today’s laboratories to thrive.
Extending the Laboratory’s Role in the Healthcare Ecosystem
In response to value-based and patient-centered coordinated care models, the healthcare industry is shifting. Accelerating the shift is the exponential growth in personalized medicine and new interoperability and reporting requirements. Since diagnostic insights have the potential to reduce overall healthcare costs and improve patient care – it is crucial that laboratories better integrate with the healthcare ecosystem. These demands are driving the need for more interaction and greater communication across all healthcare and diagnostic providers.
In this environment, an integrated LIS is a critical and central component in an efficient laboratory operations strategy. Laboratories need their technology infrastructure to support new initiatives, drive out inefficiencies, optimize their operations, and enable them to easily respond to business demands. There is no doubt that a laboratory’s LIS is the day-to-day workhorse and therefore it must be architected to meet these new demands. Those that are proactively addressing challenges and opportunities in the healthcare industry see their LIS as a critical success factor and an investment.
XIFIN LIS 5
XIFIN LIS is the most advanced laboratory information system available today. With the XIFIN technology platform as its foundation, XIFIN LIS facilitates the open but secure exchange of diagnostic, financial, and clinical information. It is a SaaS-based diagnostic solution that connects all laboratory operational components, including test ordering, lab workflow management, transcription, reporting, billing, and financial management within a single, easy-to-use, platform. It can be used as a stand-alone LIS that manages multiple test specialties, or it can be utilized to supplement the capabilities of an existing LIS that may not support a specific type of test.
Whether your facility is an early-stage molecular or genomics laboratory, an established pathology practice experiencing growth, or a mature clinical lab looking to gain efficiencies and create new revenue streams, XIFIN LIS is specifically designed to meet the varied operational needs and regulatory requirements for every kind of diagnostic laboratory.
William Blair Report: Next-Generation-Sequencing Trends in the Clinical Lab Space
William Blair conducted a survey in collaboration with The Dark Report and XIFIN to better understand next-generation sequencing trends in the clinical lab space.Download
XIFIN LIS increases laboratory testing capacity, shortens turn around time, enables the creation of new revenue models, improves operational efficiencies and makes it easier to connect to other healthcare partners. XIFIN’s modular approach provides laboratories the flexibility to choose only those workflows they require to meet their immediate needs and to readily add more when required to scale.
New Revenue Models
Improve Operational Efficiency
Advanced Capabilities Extend the LIS Beyond the Laboratory
Test-Specific Automation Gets You Started Quickly
XIFIN LIS automates and manages your diagnostic workflows—regardless of complexity or volume. With configuration driven automated workflow modules supporting 17 different testing specialties, it is easy to get started.
The advance in human genotyping and a transition to a value-based model is driving growth in molecular diagnostic (MDx) testing and complementary services. This expansion is creating data and workflow management, reporting, compliance, and specialty testing reimbursement policy issues that must be solved for today’s MDx labs to thrive.
Amid changing healthcare models, pathologists are seeing increasing demand for comprehensive reporting, collaboration, and data sharing to support multidisciplinary teams.
The frequency and cost of adverse drug events (ADEs), coupled with a shift towards a value-based healthcare model is forcing a rapid change in the healthcare landscape. As a result, the utility and application in the clinical environment of pharmacogenomics (PGx) and next-generation sequencing (NGS) test is increasing
To be successful, PGx and NGS focused laboratories must be equipped to solve the data and workflow management, reporting, compliance, and challenging reimbursement policies that are being created.
Clinical and toxicology laboratories are under pressure to optimize operational efficiencies in an increasingly challenging reimbursement environment. Higher throughput without compromising quality requires a flexible laboratory information system that can manage significant workflow variety, actively manage worklists and sample progress and take advantage of electronic connectivity from the EMR through the billing process.
Data & Workflow Management
Combining processing efficiency, workflow optimization, quality assurance, and data validation, XIFIN LIS enables laboratories to stay competitive in an increasingly complex environment. Additionally, the cloud-based SaaS architecture removes costly IT requirements, easily scales to meet the needs of laboratories of any size, and facilitates collaboration and information sharing across systems in a two-way "digital conversation."
In as little as 45 days, XIFIN LIS can be integrated and configured to connect all laboratory operational components allowing for a global, real-time view of lab activities and the automation of critical workflow steps.
This connectivity allows for a single point of entry for all laboratory processes via an intuitive, laboratory-friendly solution. Streamlining these procedures and increasing efficiencies allows laboratory staff to focus their time on improving patient care and outcomes, and less time on data entry and paper shuffling.
XIFIN LIS also includes the following Input screens and functions:
Blog Post: How to Prepare Your Lab for Next-Gen Sequencing and Big Data Science
With the growing demand for next-generation sequencing (NGS), from bases to whole genomes, and the growing demand for sequence-based drug discovery applications and diagnostic testing, there’s no denying that labs will need to accommodate a huge amount of data very soon.
Blog Post: What You Need To Know About TCPC Programs
XIFIN hosted a webinar on how to Boost Your Lab's Revenue with an Effective TCPC Program. In case you missed it, here is an overview of the big takeaways
Blog Post: Boost Your Lab's Revenue with an Effective TCPC Program
TCPC programs are a smart way for labs to drive new revenue and build stronger partnerships.
Dynamic Reporting That Drives Loyalty and Engagement with Your Clients
Comprehensive consolidated reports maximize your value and impact - combine all individual testing results into a single comprehensive summary report.
Thinking of Building or Upgrading Your Own LIS? Read This First.
The Build vs Buy Conundrum of Laboratory Information Systems
SaaS-based information systems eradicate system silos and allow labs to more easily integrate, communicate and exchange information with other systems, as opposed to the siloed solutions labs build for themselves. Plus, you never have to worry if the system expert suddenly is no longer available. For more detail on the importance of investing in SaaS-based LIS systems, read XIFIN’s “Buy vs. Build” white paper.Download White Paper
Adopting Cloud-Based Technology: Key Considerations for CEOs
Watch this video to learn more about the trends driving adoption of cloud-based technology. Standardizing on cloud-based technologies is a strategic decision. Learn how one laboratory, Applied Diagnostics, is using cloud technology across its entire organization, enabling it to participate in the value-based model while scaling its operations from a local provider to a regional business.
Boost Your Lab's Revenue Stream with an Effective TCPC Program
To help counteract ongoing lab revenue constriction, TCPC programs are a smart way for labs to drive new revenue and build stronger partnerships with physician clients.Read Now
View this XIFIN-hosted information-packed webinar that explains how to drive new revenue and build stronger relationships with clients and partners with a TCPC program.View Now
Get the datasheet on how technical component and professional component (TCPC) programs are a smart way for labs to drive new revenue sources as well as to build stronger partnerships with physician clients.Download
Single Integrated Platform, More Efficient Operations, Faster & More Accurate Claims, Richer Data
XIFIN LIS is part of a complete cloud-based laboratory platform that manages data from patient to payment. This platform includes XIFIN RPM for optimized revenue cycle management (RCM). Together, the integrated clinical data generated by XIFIN LIS and the detailed financial information from XIFIN RPM form the basis for insightful business intelligence that will help your laboratory thrive. Used together, the reimbursement process is expedited, as data is exchanged in real-time along with supporting documentation for clinical evidence and appeals support.
Compliance and Revenue Management
When XIFIN LIS and XIFIN RPM are implemented together, they share real-time web services updates to manage shared client and case information. Document upload and management are also streamlined to make the appeals and patient and payor inquiries processes more efficient, and the systems work together to automate workflows for eligibility and prior authorization. Missing patient eligibility information is also identified and corrected earlier in the reimbursement process.
Blog Post: 5 Best Practices - Secure Value from Digital Transformation Initiatives
The digital transformation wave is going to push your laboratory and profession to their limits if it hasn’t already.